Thomas Jefferson University

Jefferson Digital Commons
Department of Neurology Faculty Papers

Department of Neurology

9-1-2013

Adverse health effects of nighttime lighting: comments on
american medical association policy statement.
Richard G Stevens
George C Brainard
David E Blask
Steven W Lockley
Mario E Motta

Follow this and additional works at: https://jdc.jefferson.edu/neurologyfp

Let us know how access to this document benefits you
Recommended Citation
Stevens, Richard G; Brainard, George C; Blask, David E; Lockley, Steven W; and Motta, Mario E,
"Adverse health effects of nighttime lighting: comments on american medical association policy
statement." (2013). Department of Neurology Faculty Papers. Paper 65.
https://jdc.jefferson.edu/neurologyfp/65
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Department of Neurology Faculty Papers by an authorized administrator of the Jefferson
Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

Adverse Health Effects of Nighttime Lighting
Comments on American Medical Association Policy Statement
Richard G. Stevens, PhD, George C. Brainard, PhD, David E. Blask, PhD, MD,
Steven W. Lockley, PhD, Mario E. Motta, MD
Abstract: The American Medical Association House of Delegates in June of 2012 adopted a policy
statement on nighttime lighting and human health. This major policy statement summarizes the
scientiﬁc evidence that nighttime electric light can disrupt circadian rhythms in humans and
documents the rapidly advancing understanding from basic science of how disruption of circadian
rhythmicity affects aspects of physiology with direct links to human health, such as cell cycle
regulation, DNA damage response, and metabolism. The human evidence is also accumulating, with
the strongest epidemiologic support for a link of circadian disruption from light at night to breast
cancer. There are practical implications of the basic and epidemiologic science in the form of
advancing lighting technologies that better accommodate human circadian rhythmicity.
(Am J Prev Med 2013;45(3):343–346) & 2013 American Journal of Preventive Medicine

Electric Lighting in the Modern World

T

he American Medical Association (AMA) House
of Delegates in June of 2012 adopted a policy
statement on nighttime lighting and human
health.1 The Executive Summary states:
Biological adaptation to the sun has evolved over
billions of years. The power to artiﬁcially override the
natural cycle of light and dark is a recent event and
represents a man-made self-experiment on the effects
of exposure to increasingly bright light during the
night as human societies acquire technology and
expand industry.

Circadian Rhythms
Circadian biology is the study of daily rhythms in
physiology, metabolism, and behavior. These daily
rhythms are endogenous—spontaneously generated by
a pacemaker in the suprachiasmatic nuclei—and
expressed as such in that if a person is put into a
constant dark environment with no other time cues, that
person will exhibit approximately 24-hour rhythms in
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sleep/wake, food intake, body temperature, melatonin
production, and a vast array of other physiologic and
metabolic parameters for the rest of their natural lives.
The endogenous rhythm is slightly longer than 24 hours
in most people, and must therefore be able to be reset by
exposure to the solar cycle of light and dark to remain at
precisely 24 hours. Exposure of the eyes to bright light
during the night, which was extremely uncommon before
electricity, can disrupt this endogenous rhythmicity.
For a long time, circadian rhythmicity was viewed as
an interesting phenomenon but without any important
implications for human health. In the past decade, that
view has changed dramatically. It is now apparent that
circadian rhythmicity is central to the biology of virtually
all organisms on the planet. This is not surprising given
the primordial dominance of the 24-hour solar cycle over
life on Earth.
The Executive Summary of the AMA report1
continues:
The primary human concerns with nighttime lighting
include ... potential carcinogenic effects related to
melatonin suppression, especially breast cancer. Other
diseases that may be exacerbated by circadian disruption include obesity, diabetes, depression and
mood disorders, and reproductive problems.
These may seem to be bold statements by the AMA,
but they are not without substantial scientiﬁc support
that has been building for several decades. Exposure to
bright light after sunset is an entirely unnatural occurrence that confuses our internal regulation and how we
interact with the external environment. Light exposure at
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night triggers daytime biology, disrupting sleep, hormone
regulation, and metabolism, and abolishes the darkness
essential for regulating our circadian clock.
Pertinent to understanding human health risks are the
remarkable new scientiﬁc advances that have been made
in understanding how our endogenous circadian system
detects light (blue light is the most disruptive at night, red
the least),2 and how the small number of circadian clock
genes have a direct impact on a large proportion of our
entire genome.3 It is becoming increasingly evident that
circadian rhythmicity is crucial to overall health, including control of metabolism (how we process the food we
eat)4; DNA damage response (how we are protected from
radiation and toxic chemicals)5; and hormone production
and cell cycle regulation (both affecting how we grow and
develop and how our tissues are kept functional).6,7

Deﬁnition of “Circadian Disruption”

A deﬁnition of “circadian disruption” is important for
exposure assessment in the conduct of epidemiologic
studies. But what is meant by circadian disruption? The
deﬁnition is evolving, but in the present context it means a
perturbation of the endogenous circadian rhythmicity,
particularly by electric light exposure of the eyes during
the night. Circadian rhythmicity includes both phase and
amplitude characteristics of biologic markers that exhibit
an endogenous, approximately 24-hour rhythm, such as
circulating melatonin, circadian gene expression, and sleep.
The term circadian disruption includes disturbances such
as phase shifts of the entire circadian system, the displacement of sleep relative to the circadian clock, and/or the
acute suppression of nocturnal melatonin production
whether or not a phase shift also occurs. All these
disruptions can be elicited by ocular light exposure at night.

Light Exposure at Night and Circadian
Disruption
Melatonin is the biochemical signal of darkness—it is
only produced during the night, regardless of whether an
organism is day-active or night-active—and is found in
some form in most eukaryotes. In 1980, the seminal
observation was published that electric light during the
night suppresses melatonin production in humans8;
melatonin is a marker of circadian rhythmicity and also
has important effects on it.9 Prior to that time, it was
thought that light had little or no effect on melatonin
production in humans unlike other mammals that had
been examined.10 The light used in these experiments on
six volunteers was bright, so it was concluded by many
that only bright light could have any effect. Since then,
however, abundant evidence has demonstrated that,

depending on the exposure parameters, dim light can
also inhibit melatonin synthesis.
In fact, there is now a range of observations on light at
night in humans1 that show (1) bright light suppresses
melatonin production in all sighted people so far tested;
(2) there is a dose response in that, the brighter the light,
the greater the suppression of melatonin; (3) shorter
wavelengths (e.g., blue) are more effective than longer
wavelengths (e.g., red) for regulating neuroendocrine,
circadian, and neurobehavioral responses in humans;
and (4) there are differences among people in sensitivity
to light exposure at night. The physiology by which the
circadian system perceives light is one of the most
intriguing discoveries of modern biology; although the
retina is required, an entirely new type of photoreceptor,
the melanopsin-containing ganglion cell, is central to the
process.11
Recent research in human volunteers has focused on
real-world and practical consequences of exposure to
light at night on circadian rhythmicity and health.
Studies12,13 have now demonstrated that the lighting
levels typically found in the home in the evening, or
emitted from computer screens and electronic tablets,
can suppress melatonin secretion and affect alertness and
cognitive performance.
The impact of light on sleep is also of concern, with
both sleep disruption and circadian disruption contributing to metabolic disorders and other health problems in
humans.14 Their relative impacts have not yet been
disentangled. This distinction is important because
although darkness at night is required for preservation
of melatonin production and maintenance of circadian
rhythmicity, sleep is not. It may be normal to awake for a
period during the middle of the night,15 but as long as
one remains in the dark, this will not, by itself, cause
circadian disruption.
Therefore, disruption of circadian rhythmicity and
sleep from the indiscriminate use of electric light at night
may well increase risk of many of the diseases of modern
life, including not only certain cancers16 but also obesity,
diabetes, and psychiatric disorders.17 There is also
emerging evidence that lighting, sleep, and circadian
disruption may affect prognosis in the treatment and
therapy setting.18

The Animal Model
For investigation of hazards to human health, intervention trials are obviously unethical, and so observational
epidemiology is the only viable method for accumulating
evidence directly on humans with which to eventually
make a determination of causality. That evidence has
been accumulating, indicating a connection of light at
www.ajpmonline.org
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night and circadian disruption to breast cancer risk and
to a lesser extent other cancers and other chronic
diseases.1
Another important component of the evidence base
for determinations of causality is an animal model. The
model conceived and utilized by Blask and colleagues19
is as close as ethically possible to a direct test of the
impact of light exposure at night on growth of breast
cancer in women. A human breast cancer xenograft was
grown in a nude rat; this tumor was then perfused with
blood taken from young women at night either in the
dark or after exposure to light. The effects of these blood
samples, taken in dark or after light exposure, were
dramatically different; the sample taken during dark
virtually stopped the growth of the human tumor,
whereas the sample taken after light exposure did not
slow the tumor growth at all. This remarkable experimental model has far-ranging application and could be
utilized for investigation of a vast array of other
exposures, both chemical and physical, on growth of
human cancers.

Genetics and Epigenetics
Only recently has research begun on the potential role of
polymorphisms in circadian genes in disease etiology,
particularly cancer.20 This work may, or may not, lead to
some therapeutic or screening beneﬁts in the future.
More pertinent to the general population, however, is the
possibility that environmental exposures to circadian
disruptors, particularly light at night, might alter expression of circadian genes by, for example, changes in
promoter methylation. The ﬁrst such report21 was of
promoter hypomethylation of CLOCK, and hypermethylation of CRY2 in night-working women compared to
day workers based on a small sample of subjects. This
area deserves expansion and emphasis.

Recommendations
There are speciﬁc recommendations that come from the
emerging recognition of the importance of maintaining
robust circadian rhythmicity in our daily lives.
The conclusion of the Executive Summary1 is as
follows:
Due to the nearly ubiquitous exposure to light at
inappropriate times relative to endogenous circadian
rhythms, a need exists for further multidisciplinary
research on occupational and environmental exposure
to light-at-night, the risk of cancer, and effects on
various chronic diseases.
The AMA goes a step further in the report's recommendations and, based on existing evidence,
September 2013
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recognizes that exposure to excessive light at night,
including extended use of various electronic media,
can disrupt sleep or exacerbate sleep disorders,
especially in children and adolescents. This effect
can be minimized by using dim red lighting in the
nighttime bedroom environment.
The AMA also supports the need for
developing lighting technologies at home and at work
that minimize circadian disruption, while maintaining
visual efﬁciency.
In 2007, the International Agency for Research on
Cancer concluded that "shiftwork that involves circadian
disruption is probably carcinogenic to humans (Group
2A)."22 Studies of shift work and breast cancer conducted
since that time generally support and extend this ﬁnding.23 Elevated breast cancer risk in shift-working women
was the ﬁrst prediction of the Light-at-Night theory to be
extensively tested.16
But it is also clear that not all shift-work systems and
schedules are equally disruptive to circadian rhythmicity
and health.24 This ﬁnding offers the opportunity for
intervention and mitigation of the adverse health effects
of circadian disruption by optimizing shift systems, and
by lighting the workplace in a way that minimizes
circadian disruption throughout the shift schedule. In
modern societies, day workers are also exposed to ample
electric lighting during the night (dusk to dawn), and this
too can disrupt circadian rhythmicity in hormone
secretion and in clock gene function. Therefore, there
are many opportunities for reducing light during the
night that will improve general well-being whether or not
a scientiﬁc consensus eventually emerges that this would
also lower cancer risk.
Now, the AMA has taken this issue an important step
further. Given the large and expanding use of electric
light throughout the world, its potential impact on
human circadian rhythmicity, and the central role
played by circadian physiology in health and well-being,
these concerns should be addressed through both a
reduction in use of unnecessary lighting and technologic solutions to ensure that we can use lighting that
optimizes visual performance while minimizing circadian disruption. The impact of altered lighting on health
may be especially important to children, both because
they are growing rapidly and because of all the new
light-emitting electronic devices available today.25 The
time has come for this body of scientiﬁc evidence on
electric light effects on circadian rhythmicity, and
knowledge of the potential for harm to human health,
to fully enter the domains of medicine and public
health.
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